GNTX — Gentex Income Statement
0.000.00%
Last trade - 00:00
- $7.84bn
- $7.60bn
- $2.30bn
- 99
- 40
- 53
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,859 | 1,688 | 1,731 | 1,919 | 2,299 |
Cost of Revenue | |||||
Gross Profit | 688 | 609 | 620 | 610 | 763 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,370 | 1,289 | 1,321 | 1,549 | 1,803 |
Operating Profit | 489 | 400 | 410 | 370 | 496 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 500 | 412 | 416 | 370 | 505 |
Provision for Income Taxes | |||||
Net Income After Taxes | 425 | 348 | 361 | 319 | 428 |
Net Income Before Extraordinary Items | |||||
Net Income | 425 | 348 | 361 | 319 | 428 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 420 | 343 | 355 | 314 | 422 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.66 | 1.44 | 1.5 | 1.36 | 1.84 |
Dividends per Share |